GFH375 drug page Clinical trials

Trials with GFH375

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
1Recruiting
1Countries
775Planned patients

Showing 1–2 of 2

A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations
Recruiting Phase 1 407 patients NCT06500676

This is a multicenter, open-label, phase I/II study to explore the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of GFH375 in patients with advanced solid tumors harboring a KRAS G12D mutation.

China Jul 2024 – Dec 2028 Interventional
GFH375 Plus Cetuximab vs Investigator's Choice of Treatment in KRAS G12D-Mutant Refractory Metastatic Colorectal Cancer
Not yet recruiting Phase 3 368 patients NCT07913360

This is a Phase III trial. All enrolled subjects are patients with metastatic colorectal cancer (mCRC) harboring KRAS G12D mutations who have previously received systemic therapy. The study aims to evaluate and compare the efficacy of GFH3…

Nov 2026 – May 2030 Interventional

Where the recruiting trials are